Enanta Pharmaceuticals (ENTA) Current Deferred Revenue (2012 - 2014)
Enanta Pharmaceuticals (ENTA) posted Current Deferred Revenue of $51000.0 for Q1 2014, up 920.0% on a QoQ basis from $5000.0 in Q4 2013, and down 55.65% year-over-year from $115000.0 in Q1 2013.
Enanta Pharmaceuticals (ENTA) Current Deferred Revenue (2012 - 2014) Analysis & Trends
Enanta Pharmaceuticals' Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $51000.0 for Q1 2014.
- Quarterly Current Deferred Revenue fell 55.65% year-over-year to $51000.0 in Q1 2014, while the trailing twelve-month figure through Mar 2014 was $51000.0 (down 55.65% YoY) and the FY2013 annual result came in at $10000.0, down 41.18% from the prior year.
- Current Deferred Revenue was $51000.0 for Q1 2014 at Enanta Pharmaceuticals, up from $5000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $115000.0 in Q1 2013 and bottomed at $5000.0 in Q4 2013.
- A 3-year average of $39600.0 and a median of $17000.0 in 2012 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2013 — Current Deferred Revenue tumbled 41.18% — and 2014, when it plunged 55.65%.
- Enanta Pharmaceuticals' Current Deferred Revenue stood at $17000.0 in 2012, then slumped by 70.59% to $5000.0 in 2013, then jumped by 920.0% to $51000.0 in 2014.
- Business Quant data shows ENTA's Current Deferred Revenue at $51000.0 in Q1 2014, $5000.0 in Q4 2013, and $10000.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 375.78 Mn | 212.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 51,000.00 |
| Dec 31, 2013 | 5,000.00 |
| Sep 30, 2013 | 10,000.00 |
| Mar 31, 2013 | 115,000.00 |
| Sep 30, 2012 | 17,000.00 |